Developmental transitions allow C. albicans to adapt and survive in host niches
The capacity to undergo a reversible switch between a yeast and hyphal mode of growth is linked to the virulence of C. albicans 11, 12 .
Although other yeast species, such as the model yeast Saccharomyces cerevisiae, are capable of transitioning between different cell types, unlike S. cerevisiae, C. albicans not only grows as yeast and pseudohyphae, but it also makes true hyphae -highly elongated tubular cells with no constrictions between mother and daughter cells and a primary septum that is not degraded during cell division 13 . Hyphae enable C. albicans to conquer new environments, and mediate pathogenesis-related functions such as invasion of epithelial tissue during colonisation of mucosal surfaces and the movement of C. albicans from the gastrointestinal tract to the bloodstream 7, 13 .
Regulated gene expression is at the core of cellular pathways enabling the yeast-to-hyphae morphogenetic switch, and it is thought that the interchange between these cell types is critical for pathogenesis [13] [14] [15] [16] . Although yeast cells are considered better suited for transport via the blood in disseminated disease, whereas hyphal cells have invasive capacity, there are still a lot of questions about the specific functions of these developmental states and how they are triggered. Hyphae can switch back to yeast which is seen as yeast cells budding from the hyphal filaments 17 . Genetic mutants that cannot revert to growth as budding yeast from the hyphal forms are attenuated in virulence 17 , suggesting that the reverse transition is also important for pathogenicity.
In the human body, Candida must adapt readily to new environments as it transitions between host niches. It does so by orchestrating gene expression programs that control stress resistance, metabolic adaptation and morphogenesis 18, 19 . The innate immune response is the primary and immediate response against candidiasis, and one leukocyte in particular, the macrophage, plays an important role 7, 20 . The ability of Candida to switch between morphogenetic types is crucial for evasion of innate immunity 7, 14, 20 . When yeast forms of C. albicans are engulfed by macrophages, they can evade this line of defense by switching to hyphal growth, which leads to the hyphal filament bursting out of the macrophage and killing the host cell in the process 7, 14, 20 .
Although it is tempting (and dramatic) to speculate that these hyphae kill by exerting pressure on the macrophage membrane and physically breaking through, recent reports from our lab and others suggest that other mechanisms, related to regulation of the host-pathogen 'synapse', mediate host cell death and pathogen escape from macrophages 9, 10 .
Live cell assay of Candida-induced death of macrophages
Our lab has recently established powerful live-cell imaging to monitor the interaction of C. albicans with host macrophages using primary bone-derived macrophages from mice 9 . Using this ex vivo assay we could observe functionally distinct events over time in Phase I: C. albicans manipulation of the host macrophage
The key result that showed that C. albicans does not simply break macrophages, but rather induces a more regulated mechanism of killing, came with the realisation that macrophages derived from mice deficient in a central host immune pathway -the caspase 1 inflammasome -were protected from killing by C. albicans in the first few hours post-phagocytosis 9, 10 . This was despite normal formation of fungal hyphae, and therefore it argued that physical disruption of macrophages by fungal filaments is not the only mechanism of host cell death. Instead, it appears that the initial hyphal formation triggers the macrophage to commit suicide by a programmed cell death pathway called pyroptosis, which is enacted by caspase-1 and occurs before the filament has extended to the surface of the macrophage (Figure 1 ) 9, 10 . In addition to caspase-1, the inflammasome subunits ASC and NLRP3 are also involved in Candida-induced pyroptosis 10 . Pyroptosis is lytic, leading to . Inactivation of pyroptosis reduces macrophage death in Phase I, but does not fully protect 9, 10 , showing that C. albicans uses multiple means to escape from macrophages in the first phase of the interaction.
Key questions remain about how exactly C. albicans filaments are recognised by the caspase-1 inflammasome to trigger pyroptosis.
An intriguing C. albicans genetic mutation identified in our lab is in the Srb9 subunit of the Mediator complex (a central eukaryotic transcriptional regulator). While this mutant strain is able to transition to long hyphal filaments in the macrophage during Phase I, these filaments cannot fully exert their function in causing macrophage death 9 . We have shown that Mediator is required for proper structuring of the cell wall 9, 25 . The hyphae made by the srb9 mutant displayed lower levels of exposed b-1,3 glucan on their cell surface, which is the main component of the fungal cell wall and is immunogenic 7, 26 . The srb9 mutant hyphae also showed altered biophysical properties 9 , but how these cell surface changes are responsible for less macrophage cell death remains to be determined. Similarly, the transcriptional activator Upc2 is required for the ability of hyphal filaments to trigger pyroptosis 10 . Understanding the structural and physical properties of hyphae that are needed for signaling to the host macrophage to activate pyroptosis is the subject of current work. These factors may be reprogrammed by transcriptional regulators like the Mediator complex, as the developmental transition to hyphae begins inside the macrophage.
Phase II: macrophage necrosis or a regulated response?
Following Phase I, there is a second, quite rapid phase of macrophage killing that results in the death of the majority of remaining macrophages 9 . Very little is known about the mechanism of this second phase of killing. The second phase of killing can occur in the absence of caspase 1 or the alternative pyroptotic regulator, caspase 11 9, 10 . This excludes pyroptosis as a mechanism of macrophage death in Phase II. It has been proposed that this second phase occurs when C. albicans numbers increase, as a non-specific process 10 . It is also possible that, like Phase I, Phase II is a regulated mechanism executed by a programmed host cell death pathway 9, 24 .
On the pathogen's side, it appears that hyphal filaments are functionally involved not only in the first phase, but also in the second phase of macrophage death. The Mediator mutant med31, which is delayed in making hyphae in macrophages, triggers significantly slower Phase II of macrophage death 9 . When assayed in caspase 1/caspase 11 mutant macrophages, the srb9 mutant of C. albicans also induced a slower rate of macrophage killing in Phase II, although much faster than the hyphae-defective med31
Studying genetic mutations that uncouple hyphal morphogenesis from the ability to kill macrophages is likely to lead to better understanding of how C. albicans induces Phase II of macrophage death.
Concluding remarks
Candida albicans is a commensal organism of the skin and intestinal mucosa in approximately 50% of individuals. Breakdown of the physical barrier, due to surgery, burns or long-term use of antibiotics that reduces the numbers of competing microorganisms can lead to invasive Candida infections, even in immuno-competent patients.
There is increasing evidence that systemic Candida infections trigger immunopathological reactions that contribute to the high mortality rate despite the use of state of the art antifungal therapy.
In Focus
Dissecting the fungal factors that foster the transitions between yeast and hyphal forms, and host factors that recognise these forms, will undoubtedly reveal novel insights into the host-fungal pathogen synapse. By following these interactions on the molecular and cellular level, we will come to understand how our relationship with
Candida can suddenly turn deadly.
